Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kyorin may be among potential Japan partners for Cipla

This article was originally published in Scrip

Executive Summary

A knowledgeable source has informed Scrip that the Indian firm Cipla has initiated preliminary discussions with the Kyorin group of Japan for a potential alliance, with an eye on opportunities in the generics space. With its management succession plan in place (scripintelligence.com, 7 February 2013) and a renewed business thrust on globalization through alliances or on-the-ground presence, Cipla now appears to be setting its sights on the world's second largest pharmaceutical market. The source stressed that discussion are still at an early stage and that Cipla may also be speaking with other potential partners.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC020596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel